Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics - 28 Year Stock Price History | ORKA

Historical daily share price chart and data for Oruka Therapeutics since 1997 adjusted for splits and dividends. The latest closing stock price for Oruka Therapeutics as of January 13, 2025 is 14.03.
  • The all-time high Oruka Therapeutics stock closing price was 41803322.28 on February 18, 2000.
  • The Oruka Therapeutics 52-week high stock price is 53.90, which is 284.2% above the current share price.
  • The Oruka Therapeutics 52-week low stock price is 13.17, which is 6.1% below the current share price.
  • The average Oruka Therapeutics stock price for the last 52 weeks is 29.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Oruka Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 18.4350 19.9700 20.8100 14.0250 14.0250 -27.67%
2024 21.4367 12.2392 30.4900 11.5230 19.3900 56.37%
2023 14.8732 17.6513 18.5996 12.3632 12.3997 -28.27%
2022 16.2512 16.7761 18.4537 12.9103 17.2867 10.23%
2021 24.4176 30.3428 38.6579 15.6820 15.6820 -46.38%
2020 36.4738 41.4296 140.1167 16.9220 29.2487 -29.78%
2019 47.9482 43.3260 110.1386 36.1050 41.6535 -4.87%
2018 96.4504 177.2429 249.4529 36.7615 43.7856 -75.30%
2017 261.7010 355.7987 374.1794 137.8556 177.2429 -52.63%
2016 414.2921 609.1903 627.5711 282.2757 374.1794 -38.71%
2015 781.8426 955.7986 1387.7460 605.0940 610.5033 -30.34%
2014 1338.2544 1589.9342 2077.1158 652.5164 876.3938 -43.24%
2013 1774.5389 2260.8313 4758.7742 1102.8445 1543.9824 -26.32%
2012 3149.0491 5514.2227 5734.7916 1268.2712 2095.4046 -62.00%
2011 10308.0800 17369.8015 18141.7927 5456.3234 5514.2227 -68.45%
2010 20427.3857 18086.6505 45327.7929 14557.5479 17480.0860 -2.76%
2009 25575.8640 35291.0253 74166.2953 12407.0011 17976.3660 -47.42%
2008 82198.9703 196306.3281 204026.2398 27571.1135 34188.1807 -83.06%
2007 307781.5026 417978.0805 626415.6985 141164.1011 201820.5508 -54.25%
2006 1820717.2466 940726.3924 2282888.1972 430109.3705 441137.8159 -50.68%
2005 893566.6592 1086301.8716 1139238.4095 642958.3666 894406.9217 -17.66%
2004 1161374.0749 1191072.1029 1806459.3560 816104.9594 1086301.8716 -6.19%
2003 671225.3225 274608.2904 1356498.7838 234905.8870 1157986.7667 302.30%
2002 1047452.8598 2689837.8323 2865190.1141 287842.4249 287842.4249 -88.75%
2001 3449146.2979 4843693.2183 5713837.5602 1819693.4905 2557496.4875 -46.28%
2000 12530138.9161 5174546.5802 41803322.2771 4013251.2799 4760979.8779 -15.40%
1999 1563899.2028 1654266.8095 6001679.9850 860218.7410 5627815.6861 224.00%
1998 2925334.5288 3146415.4717 4926406.5588 1406126.7881 1736980.1500 -45.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.550B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.684B 28.35
Chugai Pharmaceutical (CHGCY) Japan $69.441B 27.05
Takeda Pharmaceutical (TAK) Japan $41.205B 8.58
Merck (MKKGY) Germany $18.882B 16.91
Sandoz Group AG (SDZNY) Switzerland $18.766B 0.00
Astellas Pharma (ALPMY) Japan $17.138B 15.78
United Therapeutics (UTHR) United States $16.294B 16.03
Neurocrine Biosciences (NBIX) United States $14.266B 37.77
Summit Therapeutics (SMMT) United States $13.163B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Madrigal Pharmaceuticals (MDGL) United States $7.392B 0.00
Orion OYJ (ORINY) Finland $6.424B 18.06
Ionis Pharmaceuticals (IONS) United States $5.283B 0.00
Corcept Therapeutics (CORT) United States $5.223B 39.56
Grifols, S.A (GRFS) Spain $5.012B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.764B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.688B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.614B 11.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
NewAmsterdam Pharma (NAMS) Netherlands $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.062B 0.00
Soleno Therapeutics (SLNO) United States $1.859B 0.00
Indivior (INDV) United States $1.634B 6.66
Dyne Therapeutics (DYN) United States $1.615B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Evotec AG (EVO) Germany $1.545B 0.00
Xencor (XNCR) United States $1.442B 0.00
Harrow (HROW) United States $1.306B 0.00
Ocular Therapeutix (OCUL) United States $1.291B 0.00
Guardian Pharmacy Services (GRDN) United States $1.266B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.155B 0.00
ARS Pharmaceuticals (SPRY) United States $1.092B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 5.79
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Cronos Group (CRON) Canada $0.757B 0.00
Bioventus (BVS) United States $0.753B 23.79
Relay Therapeutics (RLAY) United States $0.745B 0.00
USANA Health Sciences (USNA) United States $0.646B 11.97
Ironwood Pharmaceuticals (IRWD) United States $0.634B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.507B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Altimmune (ALT) United States $0.489B 0.00
OmniAb (OABI) United States $0.486B 0.00
Savara (SVRA) United States $0.477B 0.00
ProKidney (PROK) United States $0.472B 0.00
Verve Therapeutics (VERV) United States $0.468B 0.00
Esperion Therapeutics (ESPR) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.443B 5.17
Zevra Therapeutics (ZVRA) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.432B 0.00
KalVista Pharmaceuticals (KALV) United States $0.388B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Korro Bio (KRRO) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.286B 116.07
Jupiter Neurosciences (JUNS) United States $0.283B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 15.63
4D Molecular Therapeutics (FDMT) United States $0.255B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Heron Therapeutics (HRTX) United States $0.236B 0.00
Larimar Therapeutics (LRMR) United States $0.234B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Lexeo Therapeutics (LXEO) United States $0.211B 0.00
Inhibikase Therapeutics (IKT) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.190B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
MediWound (MDWD) Israel $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
Silence Therapeutics (SLN) United Kingdom $0.179B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.176B 0.00
Acrivon Therapeutics (ACRV) United States $0.170B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.144B 0.00
Cassava Sciences (SAVA) United States $0.136B 0.00
Nanobiotix S.A (NBTX) France $0.133B 0.00
Champions Oncology (CSBR) United States $0.131B 0.00
Telomir Pharmaceuticals (TELO) United States $0.122B 0.00
Metagenomi (MGX) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Inotiv (NOTV) United States $0.114B 0.00
ElectroCore (ECOR) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Century Therapeutics (IPSC) United States $0.084B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.080B 20.91
ESSA Pharma (EPIX) Canada $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
FibroGen (FGEN) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
OptiNose (OPTN) United States $0.053B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.052B 0.00
AlloVir (ALVR) United States $0.051B 0.00
VYNE Therapeutics (VYNE) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Scienture Holdings (SCNX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
BioVie (BIVI) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Traws Pharma (TRAW) United States $0.024B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SciSparc (SPRC) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Conduit Pharmaceuticals (CDT) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.98